Key Financial Data
| Key Data | Net Sales |
| Sales by Business | Pharmaceuticals: Net Sales |
| Key P&L and Cash Flow | Balance Sheet Structure |
| Per Share Data | |
Key Data
| (m €) | ||||||
|---|---|---|---|---|---|---|
| 2004 | 2005 | 2006 | 2007 | 2008 | ||
| Net Sales | 488.3 (100%) |
576.1 (100%) |
576.2 (100%) |
628.4 (100%) |
689.6 (100%) | |
| Operating Income | 90.4 (18.5%) |
111.1 (19.3%) |
120.3 (20.9%) |
131.5 (20.9%) |
144.7 (21.0%) | |
| Net Income | 54.0 (11.1%) |
64.5 (11.2%) |
74.0 (12.8%) |
84.9 (13.5%) |
100.4 (14.6%) | |
Net Sales
Sales by Business
Pharmaceuticals: Net Sales
Key P&L and Cash Flow
| (m €) | ||||||
|---|---|---|---|---|---|---|
| 2004 | 2005 | 2006 | 2007 | 2008 | ||
| Net Sales | 488.3 | 576.1 | 576.2 | 628.4 | 689.6 | |
| Gross profit as % of Sales |
309.0 63.3% |
375.5 65.2% |
384.2 66.7% |
422.1 67.2% |
467.4 67,8% | |
| Operating Income (EBIT) as % of Sales |
90.4 18.5% |
111.1 19.3% |
120.3 20.9% |
131.5 20.9% |
144.7 21.0% | |
| Pretax Income | 86.7 | 107.0 | 118.2 | 127.4 | 138.1 | |
| Net Income | 54.0 | 64.5 | 74.0 | 84.9 | 100.4 | |
| CASH FLOW | 76.9 | 89.0 | 97.3 | 113.7 | 140.3 | |
Balance Sheet Structure
Per Share Data
| 2004 | 2005 | 2006 | 2007 | 2008 | |
| Earnings per share (EPS) | 0.270 | 0.326 | 0.370 | 0.427 | 0.511 |
|---|---|---|---|---|---|
| Cash flow per share | 1.336 | 1.621 | 1.836 | 1.989 | 2.262 |
